Sari 59-801
CAS No. 80565-58-8
Sari 59-801( Sari-59-801 )
Catalog No. M28014 CAS No. 80565-58-8
Sari 59-801 is a novel, orally effective hypoglycemic compound that appears to act largely by stimulation of insulin release. SARI-59-801 was more potent in producing hypoglycemia (ED25 = 47 mg/kg) than their lean littermates (ED25 = 131 mg/kg).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 110 | In Stock |
|
| 5MG | 109 | In Stock |
|
| 10MG | 170 | In Stock |
|
| 25MG | 277 | In Stock |
|
| 50MG | 379 | In Stock |
|
| 100MG | 509 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSari 59-801
-
NoteResearch use only, not for human use.
-
Brief DescriptionSari 59-801 is a novel, orally effective hypoglycemic compound that appears to act largely by stimulation of insulin release. SARI-59-801 was more potent in producing hypoglycemia (ED25 = 47 mg/kg) than their lean littermates (ED25 = 131 mg/kg).
-
DescriptionSari 59-801 is a novel, orally effective hypoglycemic compound that appears to act largely by stimulation of insulin release. SARI-59-801 was more potent in producing hypoglycemia (ED25 = 47 mg/kg) than their lean littermates (ED25 = 131 mg/kg).(In Vivo):The 2-hr hypoglycemic ED25 in fasting mice was 110 mg/kg; the plasma insulin levels were increased, with an ED50 of 47 mg/kg. The significant hypoglycemic activity was observed 2 hr after oral administration of 59-801 to fasting rats (ED25 = 86 mg/kg), while plasma insulin was elevated by 62% at 100 mg/kg.
-
In Vitro——
-
In Vivo——
-
SynonymsSari-59-801
-
PathwayOthers
-
TargetOther Targets
-
Recptor5-HT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number80565-58-8
-
Formula Weight313.401
-
Molecular FormulaC18H23N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCc1noc(C)c1-c1[nH]c2ccccc2c1C(O)CN(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lizzie Maria Carlsson, et al. Phenylpiperidine compounds for the treatment of neurological and psychiatric disorders. US20130197032A1
molnova catalog
related products
-
TASP 0277308
TASP 0277308 is a potent and selective sphingosine 1-phosphate 1 (S1P1) receptor antagonist (IC50 = 7.8 nM). TASP 0277308 inhibits S1P-induced chemotaxis (IC50 = 1.1-1.6 nM), HUVEC cell proliferation (IC50 = 3-3.6 nM) and suppresses angiogenesisin vivo.
-
IRG1-IN-1
IRG1-IN-1, an itaconic acid derivative, inhibits Immune Response Gene 1 (IRG1) activity and is suitable for cancer, inflammation, and autoimmune disease research.
-
CLOPIDOGREL CARBOXYL...
Clopidogrel carboxylic acid (CLPM) is the inactive liver metabolite of anti platelet agent, Clopidogrel, in human serum.
Cart
sales@molnova.com